6 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 6 of 6 clinical reviews.
A guide to isotretinoin's delayed-onset and post-treatment adverse events, covering musculoskeletal, psychiatric, inflammatory bowel, ocular, and endocrine effects, with an evidence-tiered review of what is established, what is plausible, and what still needs verification.
A deep dive into the rare but serious adverse events associated with isotretinoin (Accutane), covering psychiatric effects, teratogenicity, IBD, pseudotumor cerebri, hepatotoxicity, and more, with primary-source citations throughout.
A comprehensive guide to isotretinoin adverse events, withdrawal and discontinuation phenomena, rare side effects, and post-course management, with primary citations from PubMed, FDA, and clinical trial data.
A data-driven breakdown of isotretinoin adverse event rates drawn from key clinical trials, the FDA label, FAERS reports, and post-market literature. prepared by the HealthRX.com Editorial Team.
A comprehensive guide to potentially permanent side effects of isotretinoin (Accutane), including musculoskeletal, psychiatric, teratogenic, and ocular risks, with specific trial data, FDA label citations, and clinical guidance.
A clinical breakdown of isotretinoin adverse events by severity grade and patient phenotype, distinguishing FDA-labeled effects from pharmacovigilance signals and areas that still require verification against current primary literature.